SLC5A2 and hydrops fetalis: Both DAPA-HF [8] and EMPEROR-Reduced [16] reported that the SGLT2 inhibitor groups demonstrated a slower decrease in estimated glomerular filtration rate (eGFR) and experienced a reduced number of renal composite events.